The overlooked difference between human endogenous and recombinant erythropoietins and its implication for sports drug testing and pharmaceutical drug design-Reference-Cited by-同舟云学术

The overlooked difference between human endogenous and recombinant erythropoietins and its implication for sports drug testing and pharmaceutical drug design

Published:2011-11 Issue:11-12 Volume:3 Page:883-891
ISSN:1942-7603
Container-title:Drug Testing and Analysis
language:en
Short-container-title:Drug Test. Analysis

Author:

Reichel Christian¹

Affiliation:

1. Doping Control Laboratory; AIT Seibersdorf Laboratories; A-2444; Seibersdorf; Austria

Publisher

Wiley

Subject

Spectroscopy,Pharmaceutical Science,Environmental Chemistry,Analytical Chemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/dta.388/fullpdf

Reference60 articles.

1. Role of the Kidney in Erythropoiesis

2. PROGRESS IN THE PURIFICATION OF ERYTHROPOIETIN

3. Purification of Erythropoietin

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Satisfying QTPP of Erythropoietin Biosimilar by QbD through DoE-Derived Downstream Process Engineering;Pharmaceutics;2023-08-04

2. Detection and quantification of the metabolite Ac‐Tβ_1–14 in in vitro experiments and urine of rats treated with Ac‐Tβ4: A potential biomarker of Ac‐Tβ4 for doping tests;Drug Testing and Analysis;2023-07-28

3. Development and qualification of a high-yield recombinant human Erythropoietin biosimilar;2023-01-22

4. A Cost-effective Purification Process for Erythropoietin Biosimilar through Downstream Process Engineering;2023-01-18

5. A simple method to immunopurify erythropoiesis stimulating agents from urine, aiming to optimize erythropoietin screening by SAR‐PAGE;Drug Testing and Analysis;2019-11